In the US, compounding occurs under two regulatory categories: 503A compounding pharmacies cover the traditional role of customizing drugs for individual patients, while 503B compounding pharmacies can produce compounded drugs in bulk when certain conditions, such as a shortage, are met
, There are also findings that Alcar is capable of offering neurotherapeutic benefits to its users as well as reducing the symptoms of male aging, namely improving mood and reducing fatigue
503B outsourcing facilities were given a deadline to cease production, and 503A pharmacies are restricted to patient-specific prescriptions only
Weight loss varies significantly across individuals
Details reflect the label and brand materials reviewed in July 2026
doi:10.1093/femsre/fuad008